Lifeward (LFWD) Debt Ratio (2016 - 2025)
Lifeward's (LFWD) quarterly Debt Ratio came in at 0.12 in Q4 2025, down 6.49% quarter-over-quarter from 0.13 in Q3 2020.
Analysis
Lifeward (LFWD) Debt Ratio (2016 - 2025) Analysis & Trends
Lifeward has disclosed Debt Ratio across 6 years of filings, most recently posting 0.12 for Q4 2025.
- In Q4 2025, Debt Ratio changed N/A year-over-year to 0.12; the TTM figure through Dec 2025 stood at 0.12 (changed N/A YoY), while the FY2025 annual figure was 0.12, changed N/A from the prior year.
- Debt Ratio came in at 0.12 for Q4 2025 at Lifeward, down from 0.13 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.12 in Q4 2025 to a low of 0.12 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 0.30 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 0.30 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 0.31 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 0.28 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 0.04 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.13 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 0.20 |
| 10 | Lifeward | 19.77 Mn | 10.32 Mn | 2.71 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 0.12 |
| Sep 30, 2020 | 0.13 |
| Jun 30, 2020 | 0.21 |
| Mar 31, 2020 | 0.23 |
| Dec 31, 2019 | 0.29 |
| Sep 30, 2019 | 0.26 |
| Jun 30, 2019 | 0.25 |
| Mar 31, 2019 | 0.49 |
| Dec 31, 2018 | 0.58 |
| Sep 30, 2018 | 1.05 |
| Jun 30, 2018 | 0.77 |
| Mar 31, 2018 | 0.80 |
| Dec 31, 2017 | 0.67 |
| Sep 30, 2017 | 0.73 |
| Jun 30, 2017 | 0.66 |
| Mar 31, 2017 | 0.67 |
| Dec 31, 2016 | 0.57 |
| Sep 30, 2016 | 0.50 |
| Jun 30, 2016 | 0.42 |
| Mar 31, 2016 | 0.33 |